Common Contracts
19 similar Sales Agreement contracts by Agile Therapeutics Inc, Capricor Therapeutics, Inc., CASI Pharmaceuticals, Inc., others
CASI PHARMACEUTICALS, inc. cOMMON STOCK SALES AGREEMENTSales Agreement • October 29th, 2021 • CASI Pharmaceuticals, Inc. • Biological products, (no disgnostic substances) • New York
AGILE THERAPEUTICS, INC. COMMON STOCK SALES AGREEMENTSales Agreement • March 18th, 2021 • Agile Therapeutics Inc • Pharmaceutical preparations • New York
FLUX POWER HOLDINGS, INC. cOMMON STOCK SALES AGREEMENTSales Agreement • December 21st, 2020 • Flux Power Holdings, Inc. • Miscellaneous electrical machinery, equipment & supplies • New York
Flux Power Holdings, Inc., a Nevada corporation (the “Company”), confirms its agreement (this “Agreement”) with H.C. Wainwright & Co., LLC (“HCW”), as follows:
AGILE THERAPEUTICS, INC. COMMON STOCK SALES AGREEMENTSales Agreement • November 8th, 2019 • Agile Therapeutics Inc • Pharmaceutical preparations • New York
CAPRICOR THERAPEUTICS, INC. cOMMON STOCK SALES AGREEMENTSales Agreement • July 22nd, 2019 • Capricor Therapeutics, Inc. • Pharmaceutical preparations • New York
PROTEOSTASIS THERAPEUTICS, INC. COMMON STOCK SALES AGREEMENTSales Agreement • May 9th, 2019 • Proteostasis Therapeutics, Inc. • Pharmaceutical preparations • New York
Proteostasis Therapeutics, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with H.C. Wainwright & Co., LLC (“HCW”), as follows:
COMMON STOCK SALES AGREEMENTSales Agreement • April 17th, 2019 • Trevena Inc • Pharmaceutical preparations • New York
Trevena, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with H.C. Wainwright & Co., LLC (“HCW”), as follows:
AGILE THERAPEUTICS, INC. COMMON STOCK SALES AGREEMENTSales Agreement • January 23rd, 2019 • Agile Therapeutics Inc • Pharmaceutical preparations • New York
XOMA CORPORATION COMMON STOCK SALES AGREEMENTSales Agreement • December 18th, 2018 • XOMA Corp • Pharmaceutical preparations • New York
REGULUS THERAPEUTICS INC. COMMON STOCK SALES AGREEMENTSales Agreement • December 12th, 2018 • Regulus Therapeutics Inc. • Pharmaceutical preparations • New York
CYCLACEL PHARMACEUTICALS, INC. cOMMON STOCK SALES AGREEMENTSales Agreement • October 4th, 2018 • Cyclacel Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Cyclacel Pharmaceuticals, Inc. (the “Company”), confirms its agreement (this “Agreement”) with H.C. Wainwright & Co., LLC (“HCW”), as follows:
RESHAPE LIFESCIENCES, INC. COMMON STOCK SALES AGREEMENTSales Agreement • October 3rd, 2018 • ReShape Lifesciences Inc. • Electromedical & electrotherapeutic apparatus • New York
MYOS RENS TECHNOLOGY INC. COMMON STOCK SALES AGREEMENTSales Agreement • July 24th, 2018 • Myos Rens Technology Inc. • Pharmaceutical preparations • New York
CASI PHARMACEUTICALS, INC. COMMON STOCK SALES AGREEMENTSales Agreement • February 23rd, 2018 • CASI Pharmaceuticals, Inc. • Biological products, (no disgnostic substances) • New York
DARÉ BIOSCIENCE, INC. COMMON STOCK SALES AGREEMENTSales Agreement • January 4th, 2018 • Dare Bioscience, Inc. • Pharmaceutical preparations • New York
CAPRICOR THERAPEUTICS, INC. $14,000,000 cOMMON STOCK SALES AGREEMENTSales Agreement • October 19th, 2017 • Capricor Therapeutics, Inc. • Pharmaceutical preparations • New York
SAVARA INC. COMMON STOCK SALES AGREEMENTSales Agreement • April 28th, 2017 • Savara Inc • Pharmaceutical preparations • New York
MYOS RENS TECHNOLOGy inc. cOMMON STOCK SALES AGREEMENTSales Agreement • February 21st, 2017 • Myos Rens Technology Inc. • Pharmaceutical preparations • New York
SALES AGREEMENTSales Agreement • June 28th, 2016 • Aethlon Medical Inc • Laboratory analytical instruments • New York
